Found an issue? Give us feedback

Link to

shareShare

uploadDeposit

codeEmbed

downloadDownload

Select content type to embed

All Research products

arrow_drop_down

<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=inca________::36670ab091a77fa249f5b335f2b778fe&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

Phase I/II study of ABT-263 in combination with carboplatin to reverse platinum resistance in ovarian cancer NAVICARBO protocol

assignment_turned_inproject

Funder: Institut National du CancerProject code: INCa-DGOS-3695 Call for proposal: PHRC11

Funded under: PHRC

Phase I/II study of ABT-263 in combination with carboplatin to reverse platinum resistance in ovarian cancer NAVICARBO protocol

- Summary
- DMPs

Partners

Centre Oscar Lambret , Centre Eugène Marquis , Institut de Cancérologie de l'Ouest - ICO , Centre François Baclesse

Data Management Plans

Start a new DMP in Argos

Found an issue? Give us feedback

Select content type to embed

All Research products

arrow_drop_down

<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=inca________::36670ab091a77fa249f5b335f2b778fe&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

Phase I/II study of ABT-263 in combination with carboplatin to reverse platinum resistance in ovarian cancer NAVICARBO protocol

Phase I/II study of ABT-263 in combination with carboplatin to reverse platinum resistance in ovarian cancer NAVICARBO protocol

Loading